Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant kallikrein inhibitor

EU orphan designation number: EU/3/09/712   
Active ingredient: Recombinant kallikrein inhibitor
Indication: Treatment of Netherton syndrome
Sponsor: Dermadis S.A.S.
Technopole d’Archamps, Bâtiment Le Forum II, F-74160 Archamps, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/02/2010 Centralised Orphan - Designation EMEA/OD/106/09 (2010)712 of 29/01/2010
13/01/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/106/09/T/01 (2012)136 of 11/01/2012